glp 1 function GLP-1: Actions on Beta-cell Mass and Emerging Frontiers in GLP-1 Therapeutics:

Oyama J, Murohara T, Kitakaze M, Ishizu T, Sato Y, Kitagawa K, et al

[DOI] [PubMed] [Google Scholar] 164.Nrregaard P.K., Deryabina M.A., Tofteng Shelton P., Fog J.U., Daugaard J.R., Eriksson P.O., Larsen L.F., Jessen L

Nutritional priorities to support GLP-1 therapy for weight reduction A pragmatic approach to nutrition and lifestyle counseling and support is recommended to maximize benefits, minimize potential risks, and increase efficiency of GLP-1 therapy for weight reduction

21 Liraglutide showed no effect on the hierarchical primary endpoint of time to death, time to rehospitalisation for HF and time-averaged change in N-terminal pro B-type natriuretic peptide (NT-proBNP) from baseline to 180 days (p=0.31), with even an increased risk of emergency department visit, HF hospitalisation or all-cause death events (HR 1.36

Compounded GLP-1 vs FDA-Approved Zepbound & Wegovy - Cincinnati Weight Loss 3/3/2026 Compounded GLP-1 vs FDA-Approved Zepbound & Wegovy: What Patients in Cincinnati Should Know Over the past year, GLP-1 medications have transformed the conversation around medical weight loss